Objective To review of the existing literature, current guidelines and standard of practice
related to prostate cancer in transgender women, as the transgender population share many …

Introduction As the transgender patient population continues to increase, urologists and
other providers who treat genitourinary malignancies will increasingly encounter cases of …

Objective To critically analyze the available evidence regarding the incidence,
etiopathogenesis, and management of prostate cancer (CaP) in transgender women. In …

Abstract Transgender individuals represent 0.55% of the US population, equivalent to 1.4
million transgender adults. In transgender women, feminisation can include a number of …

Abstract Purpose of Review To systematically review the evidence on prostate cancer (PCa)
in transgender women (TGW). Recent Findings A total of 25 studies were included. Fourteen …

Prostate cancer in sexual and gender minorities is an emerging medical and public health
concern. The purpose of this review is to summarize the state of the science on prostate …

Abstract Male-to-female (MtF) transgender individuals are at risk for prostate cancer,
although guidelines for screening and management in this population are not well …

Abstract Context Approximately 0.4–1.3% of the worldwide population is transgender.
Although the exact prevalence is unknown, there is an increase in open identification as …

Transgender women, who were assigned male at birth but identify as women, may take
several steps to merge their physical and psychological identities, including gender …

Introduction Factors influencing patient behavior regarding risk of prostate cancer (PCa) and
outcomes of PCa treatments are poorly understood. Similarly, how PCa treatments affect …